Department of Veterans Affairs VISN 17 Center of Excellence (CoE) for Research on Returning War Vete, Central Texas Veterans Health Care System (CTVHCS), Waco, TX, USA
Review Article
Methods and Compliance Adopted in Controlling Infectivity of COVID-19/SARS-CoV-2 and facilitating Sample/ Specimen Handling under BSL-2 Containment for Research and Process Development Activities
Author(s): Rakeshwar S Guleria*
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has presented the healthcare and scientific research community with
an uphill task in testing, controlling, and finding the prevention or cure for the pandemic. A significant amount of challenge related to testing and
research activities arise as SARS-CoV-2 is a risk group 3 (RG3) agent and requires for all activities that use live virus for diagnostics, screening,
surveillance, process development and scientific research to be handled in the Biosafety Level-3 (BSL-3) biocontainment facility environment. Low
availability of the BSL-3 laboratories presents a daunting challenge for health care and research personnel, globally. Therefore, specific sample
manipulation followed by risk assessment approach will allow the work to be carried in a Biosafety Level-2 (BSL-2) laboratory with enhanced
practice.. Read More»
DOI:
10.37421/2736-6189.2021.6.242
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 